larg Search Results


93
Cusabio anti arhgef12
Anti Arhgef12, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/larg/Rabbit+anti-+ARHGEF12+Polyclonal+Antibody/pmc12661753-227-23-24
Average 93 stars, based on 1 article reviews
anti arhgef12 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology larg
Larg, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/larg/LARG+Antibody/pmc04615130-228-46-47
Average 94 stars, based on 1 article reviews
larg - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology larg sc 41801
Larg Sc 41801, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/larg/LARG+siRNA/pmc03891622-200-26-29
Average 93 stars, based on 1 article reviews
larg sc 41801 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

92
Addgene inc 2xpdz domain
2xpdz Domain, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/larg/PR_GEF+(2XPDZ-mCherry-Larg+(DH)+(Plasmid+%2380407)/pmc06408446-252-9-12
Average 92 stars, based on 1 article reviews
2xpdz domain - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

93
Proteintech cat cy5640 rabbit polyclonal anti arhgef12
Fig. 6 Palmitoylated GNA13 promotes the expression of RhoA protein in C18 - 4 cells by binding to <t>ARHGEF12.</t> A C18 - 4 cells transfected with control vector or HA-GNA13 were lysed, anti-HA antibody was used for immunopurification, and irrelevant IgG was used for control. We used mass spectrometry to analyze protein bands that were acquired by dealing with eluent with silver staining. Some binding proteins were verified in C18 - 4 cells. B and C Differential enrichment analysis of HA and IgG groups in Co-IP pull-down assay. D and E Interactive analysis of STRING data and Co-IP mass spectrometry results. F C18 - 4 cells transfected with WT-GNA13 and GNA13-C14/18S for 24 h. Whole cell lysates (WCL) were used for Co-IP and western blotting with anti-HA and irrelevant IgG (Control). G Representative images of GNA13 immunostaining colocalization with ARHGEF12 in C18 - 4 cells with transfecting WT-GNA13 and GNA13-C14/18S for 24 h. Scale bars, 50 µm. H Western blot analysis was performed to determine changes of RhoA when WT-GNA13 or GNA13-C14/18S were transfected in C18 - 4 cells for 24 h
Cat Cy5640 Rabbit Polyclonal Anti Arhgef12, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/larg/LARG+Antibody/pm40205436-166-85-88
Average 93 stars, based on 1 article reviews
cat cy5640 rabbit polyclonal anti arhgef12 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Addgene inc michael glotzer
Fig. 6 Palmitoylated GNA13 promotes the expression of RhoA protein in C18 - 4 cells by binding to <t>ARHGEF12.</t> A C18 - 4 cells transfected with control vector or HA-GNA13 were lysed, anti-HA antibody was used for immunopurification, and irrelevant IgG was used for control. We used mass spectrometry to analyze protein bands that were acquired by dealing with eluent with silver staining. Some binding proteins were verified in C18 - 4 cells. B and C Differential enrichment analysis of HA and IgG groups in Co-IP pull-down assay. D and E Interactive analysis of STRING data and Co-IP mass spectrometry results. F C18 - 4 cells transfected with WT-GNA13 and GNA13-C14/18S for 24 h. Whole cell lysates (WCL) were used for Co-IP and western blotting with anti-HA and irrelevant IgG (Control). G Representative images of GNA13 immunostaining colocalization with ARHGEF12 in C18 - 4 cells with transfecting WT-GNA13 and GNA13-C14/18S for 24 h. Scale bars, 50 µm. H Western blot analysis was performed to determine changes of RhoA when WT-GNA13 or GNA13-C14/18S were transfected in C18 - 4 cells for 24 h
Michael Glotzer, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/larg/PR_GEF+YFP+(2XPDZ-YFP-LARG+DH)+(Plasmid+%2380408)/pm31501561-242-122-124
Average 90 stars, based on 1 article reviews
michael glotzer - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
R&D Systems polyclonal goat antibody against larg
( a ) Quantification of endothelial pore size in <t>LARG,</t> p115RhoGEF or Ect2 depleted ECs. ( b ) Quantification of endothelial pore size during early, mid and late diapedesis in control versus LARG+Ect2 depleted ECs. ( c ) Quantification of F-actin-positive ring structures and F-actin-positive apical protrusions in control versus LARG+Ect2 depleted ECs.( d ) Quantification of FITC–dextran and neutrophil extravasation after 20 min of neutrophil transmigration through control and Ect2/LARG ( d ) or ICAM-1-deficient ECs ( e ). ( f ) Model of endothelial pore formation. Adherent leukocytes destabilizing cell–cell junctions subsequently insert small pseudopodia between transient openings in the endothelium (leukocyte probing) during early diapedesis. The next step (mid diapedesis) involves local and transient RhoA activation that mediates endothelial pore confinement through the formation of a de novo basolateral F-actin ring and actomyosin contractility. Finally, persistent actomyosin contractility closes the endothelial pore behind transmigrating leukocytes. ICAM-1 is involved in the regulation of endothelial pore confinement through recruitment of the Rho GEFs LARG and Ect2. Basolateral F-actin ring formation and actomyosin contractility tightens the endothelial barrier during leukocyte diapedesis, making the leukocyte-induced endothelial pore impermeable for macromolecules. **** P <0.0001 (ANOVA) ( a – c ).** P <0.01 (ANOVA) ( b ) * P <0.05 (ANOVA) ( e , d ).* P <0.05 control versus siLARG/shEct2 ( d ) ** P <0.01 control versus siICAM-1 ( e ) (Student's t -test). Data are representative of three independent experiments ( a – e ) with >12 transmigration events per group ( a – c ) (error bars ( a – e ) s.e.m). ANOVA, analysis of variance.
Polyclonal Goat Antibody Against Larg, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/larg/Human+LARG+Antibody/pmc04737874-201-0-12
Average 90 stars, based on 1 article reviews
polyclonal goat antibody against larg - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

92
Fortis Life Sciences rabbit a301 959a
( a ) Quantification of endothelial pore size in <t>LARG,</t> p115RhoGEF or Ect2 depleted ECs. ( b ) Quantification of endothelial pore size during early, mid and late diapedesis in control versus LARG+Ect2 depleted ECs. ( c ) Quantification of F-actin-positive ring structures and F-actin-positive apical protrusions in control versus LARG+Ect2 depleted ECs.( d ) Quantification of FITC–dextran and neutrophil extravasation after 20 min of neutrophil transmigration through control and Ect2/LARG ( d ) or ICAM-1-deficient ECs ( e ). ( f ) Model of endothelial pore formation. Adherent leukocytes destabilizing cell–cell junctions subsequently insert small pseudopodia between transient openings in the endothelium (leukocyte probing) during early diapedesis. The next step (mid diapedesis) involves local and transient RhoA activation that mediates endothelial pore confinement through the formation of a de novo basolateral F-actin ring and actomyosin contractility. Finally, persistent actomyosin contractility closes the endothelial pore behind transmigrating leukocytes. ICAM-1 is involved in the regulation of endothelial pore confinement through recruitment of the Rho GEFs LARG and Ect2. Basolateral F-actin ring formation and actomyosin contractility tightens the endothelial barrier during leukocyte diapedesis, making the leukocyte-induced endothelial pore impermeable for macromolecules. **** P <0.0001 (ANOVA) ( a – c ).** P <0.01 (ANOVA) ( b ) * P <0.05 (ANOVA) ( e , d ).* P <0.05 control versus siLARG/shEct2 ( d ) ** P <0.01 control versus siICAM-1 ( e ) (Student's t -test). Data are representative of three independent experiments ( a – e ) with >12 transmigration events per group ( a – c ) (error bars ( a – e ) s.e.m). ANOVA, analysis of variance.
Rabbit A301 959a, supplied by Fortis Life Sciences, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/larg/LARG+Antibody/pmc03771942-168-13-15
Average 92 stars, based on 1 article reviews
rabbit a301 959a - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

88
Santa Cruz Biotechnology larg arhgef12 crispr cas9 knockout plasmid
( a ) Quantification of endothelial pore size in <t>LARG,</t> p115RhoGEF or Ect2 depleted ECs. ( b ) Quantification of endothelial pore size during early, mid and late diapedesis in control versus LARG+Ect2 depleted ECs. ( c ) Quantification of F-actin-positive ring structures and F-actin-positive apical protrusions in control versus LARG+Ect2 depleted ECs.( d ) Quantification of FITC–dextran and neutrophil extravasation after 20 min of neutrophil transmigration through control and Ect2/LARG ( d ) or ICAM-1-deficient ECs ( e ). ( f ) Model of endothelial pore formation. Adherent leukocytes destabilizing cell–cell junctions subsequently insert small pseudopodia between transient openings in the endothelium (leukocyte probing) during early diapedesis. The next step (mid diapedesis) involves local and transient RhoA activation that mediates endothelial pore confinement through the formation of a de novo basolateral F-actin ring and actomyosin contractility. Finally, persistent actomyosin contractility closes the endothelial pore behind transmigrating leukocytes. ICAM-1 is involved in the regulation of endothelial pore confinement through recruitment of the Rho GEFs LARG and Ect2. Basolateral F-actin ring formation and actomyosin contractility tightens the endothelial barrier during leukocyte diapedesis, making the leukocyte-induced endothelial pore impermeable for macromolecules. **** P <0.0001 (ANOVA) ( a – c ).** P <0.01 (ANOVA) ( b ) * P <0.05 (ANOVA) ( e , d ).* P <0.05 control versus siLARG/shEct2 ( d ) ** P <0.01 control versus siICAM-1 ( e ) (Student's t -test). Data are representative of three independent experiments ( a – e ) with >12 transmigration events per group ( a – c ) (error bars ( a – e ) s.e.m). ANOVA, analysis of variance.
Larg Arhgef12 Crispr Cas9 Knockout Plasmid, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/larg/LARG+CRISPR%2FCas9+KO+Plasmid/pmc05777029-168-13-19
Average 88 stars, based on 1 article reviews
larg arhgef12 crispr cas9 knockout plasmid - by Bioz Stars, 2026-11
88/100 stars
  Buy from Supplier

93
Addgene inc larg mcherry sspb
( a ) Quantification of endothelial pore size in <t>LARG,</t> p115RhoGEF or Ect2 depleted ECs. ( b ) Quantification of endothelial pore size during early, mid and late diapedesis in control versus LARG+Ect2 depleted ECs. ( c ) Quantification of F-actin-positive ring structures and F-actin-positive apical protrusions in control versus LARG+Ect2 depleted ECs.( d ) Quantification of FITC–dextran and neutrophil extravasation after 20 min of neutrophil transmigration through control and Ect2/LARG ( d ) or ICAM-1-deficient ECs ( e ). ( f ) Model of endothelial pore formation. Adherent leukocytes destabilizing cell–cell junctions subsequently insert small pseudopodia between transient openings in the endothelium (leukocyte probing) during early diapedesis. The next step (mid diapedesis) involves local and transient RhoA activation that mediates endothelial pore confinement through the formation of a de novo basolateral F-actin ring and actomyosin contractility. Finally, persistent actomyosin contractility closes the endothelial pore behind transmigrating leukocytes. ICAM-1 is involved in the regulation of endothelial pore confinement through recruitment of the Rho GEFs LARG and Ect2. Basolateral F-actin ring formation and actomyosin contractility tightens the endothelial barrier during leukocyte diapedesis, making the leukocyte-induced endothelial pore impermeable for macromolecules. **** P <0.0001 (ANOVA) ( a – c ).** P <0.01 (ANOVA) ( b ) * P <0.05 (ANOVA) ( e , d ).* P <0.05 control versus siLARG/shEct2 ( d ) ** P <0.01 control versus siICAM-1 ( e ) (Student's t -test). Data are representative of three independent experiments ( a – e ) with >12 transmigration events per group ( a – c ) (error bars ( a – e ) s.e.m). ANOVA, analysis of variance.
Larg Mcherry Sspb, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/larg/LARG+mCherry+sspB+in+pcDNA3%2E1+(Plasmid+%2390459)/bio_rxiv__2025__06__18__658998-169-29-30
Average 93 stars, based on 1 article reviews
larg mcherry sspb - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

85
Thermo Fisher gene exp arhgef12 rn01417838 m1
( a ) Quantification of endothelial pore size in <t>LARG,</t> p115RhoGEF or Ect2 depleted ECs. ( b ) Quantification of endothelial pore size during early, mid and late diapedesis in control versus LARG+Ect2 depleted ECs. ( c ) Quantification of F-actin-positive ring structures and F-actin-positive apical protrusions in control versus LARG+Ect2 depleted ECs.( d ) Quantification of FITC–dextran and neutrophil extravasation after 20 min of neutrophil transmigration through control and Ect2/LARG ( d ) or ICAM-1-deficient ECs ( e ). ( f ) Model of endothelial pore formation. Adherent leukocytes destabilizing cell–cell junctions subsequently insert small pseudopodia between transient openings in the endothelium (leukocyte probing) during early diapedesis. The next step (mid diapedesis) involves local and transient RhoA activation that mediates endothelial pore confinement through the formation of a de novo basolateral F-actin ring and actomyosin contractility. Finally, persistent actomyosin contractility closes the endothelial pore behind transmigrating leukocytes. ICAM-1 is involved in the regulation of endothelial pore confinement through recruitment of the Rho GEFs LARG and Ect2. Basolateral F-actin ring formation and actomyosin contractility tightens the endothelial barrier during leukocyte diapedesis, making the leukocyte-induced endothelial pore impermeable for macromolecules. **** P <0.0001 (ANOVA) ( a – c ).** P <0.01 (ANOVA) ( b ) * P <0.05 (ANOVA) ( e , d ).* P <0.05 control versus siLARG/shEct2 ( d ) ** P <0.01 control versus siICAM-1 ( e ) (Student's t -test). Data are representative of three independent experiments ( a – e ) with >12 transmigration events per group ( a – c ) (error bars ( a – e ) s.e.m). ANOVA, analysis of variance.
Gene Exp Arhgef12 Rn01417838 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/larg/Gene+Exp%2E+Arhgef12%2C+Rn01417838_m1/pm30962047-55-40-14
Average 85 stars, based on 1 article reviews
gene exp arhgef12 rn01417838 m1 - by Bioz Stars, 2026-11
85/100 stars
  Buy from Supplier

92
Thermo Fisher gene exp arhgef12 hs00209661 m1
( a ) Quantification of endothelial pore size in <t>LARG,</t> p115RhoGEF or Ect2 depleted ECs. ( b ) Quantification of endothelial pore size during early, mid and late diapedesis in control versus LARG+Ect2 depleted ECs. ( c ) Quantification of F-actin-positive ring structures and F-actin-positive apical protrusions in control versus LARG+Ect2 depleted ECs.( d ) Quantification of FITC–dextran and neutrophil extravasation after 20 min of neutrophil transmigration through control and Ect2/LARG ( d ) or ICAM-1-deficient ECs ( e ). ( f ) Model of endothelial pore formation. Adherent leukocytes destabilizing cell–cell junctions subsequently insert small pseudopodia between transient openings in the endothelium (leukocyte probing) during early diapedesis. The next step (mid diapedesis) involves local and transient RhoA activation that mediates endothelial pore confinement through the formation of a de novo basolateral F-actin ring and actomyosin contractility. Finally, persistent actomyosin contractility closes the endothelial pore behind transmigrating leukocytes. ICAM-1 is involved in the regulation of endothelial pore confinement through recruitment of the Rho GEFs LARG and Ect2. Basolateral F-actin ring formation and actomyosin contractility tightens the endothelial barrier during leukocyte diapedesis, making the leukocyte-induced endothelial pore impermeable for macromolecules. **** P <0.0001 (ANOVA) ( a – c ).** P <0.01 (ANOVA) ( b ) * P <0.05 (ANOVA) ( e , d ).* P <0.05 control versus siLARG/shEct2 ( d ) ** P <0.01 control versus siICAM-1 ( e ) (Student's t -test). Data are representative of three independent experiments ( a – e ) with >12 transmigration events per group ( a – c ) (error bars ( a – e ) s.e.m). ANOVA, analysis of variance.
Gene Exp Arhgef12 Hs00209661 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/larg/Gene+Exp%2E+ARHGEF12%2C+Hs00209661_m1/pmc10569644-279-23-26
Average 92 stars, based on 1 article reviews
gene exp arhgef12 hs00209661 m1 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

Image Search Results


Fig. 6 Palmitoylated GNA13 promotes the expression of RhoA protein in C18 - 4 cells by binding to ARHGEF12. A C18 - 4 cells transfected with control vector or HA-GNA13 were lysed, anti-HA antibody was used for immunopurification, and irrelevant IgG was used for control. We used mass spectrometry to analyze protein bands that were acquired by dealing with eluent with silver staining. Some binding proteins were verified in C18 - 4 cells. B and C Differential enrichment analysis of HA and IgG groups in Co-IP pull-down assay. D and E Interactive analysis of STRING data and Co-IP mass spectrometry results. F C18 - 4 cells transfected with WT-GNA13 and GNA13-C14/18S for 24 h. Whole cell lysates (WCL) were used for Co-IP and western blotting with anti-HA and irrelevant IgG (Control). G Representative images of GNA13 immunostaining colocalization with ARHGEF12 in C18 - 4 cells with transfecting WT-GNA13 and GNA13-C14/18S for 24 h. Scale bars, 50 µm. H Western blot analysis was performed to determine changes of RhoA when WT-GNA13 or GNA13-C14/18S were transfected in C18 - 4 cells for 24 h

Journal: Cell communication and signaling : CCS

Article Title: Zinc finger DHHC-type palmitoyltransferase 13-mediated S-palmitoylation of GNA13 from Sertoli cell-derived extracellular vesicles inhibits autophagy in spermatogonial stem cells.

doi: 10.1186/s12964-025-02177-0

Figure Lengend Snippet: Fig. 6 Palmitoylated GNA13 promotes the expression of RhoA protein in C18 - 4 cells by binding to ARHGEF12. A C18 - 4 cells transfected with control vector or HA-GNA13 were lysed, anti-HA antibody was used for immunopurification, and irrelevant IgG was used for control. We used mass spectrometry to analyze protein bands that were acquired by dealing with eluent with silver staining. Some binding proteins were verified in C18 - 4 cells. B and C Differential enrichment analysis of HA and IgG groups in Co-IP pull-down assay. D and E Interactive analysis of STRING data and Co-IP mass spectrometry results. F C18 - 4 cells transfected with WT-GNA13 and GNA13-C14/18S for 24 h. Whole cell lysates (WCL) were used for Co-IP and western blotting with anti-HA and irrelevant IgG (Control). G Representative images of GNA13 immunostaining colocalization with ARHGEF12 in C18 - 4 cells with transfecting WT-GNA13 and GNA13-C14/18S for 24 h. Scale bars, 50 µm. H Western blot analysis was performed to determine changes of RhoA when WT-GNA13 or GNA13-C14/18S were transfected in C18 - 4 cells for 24 h

Article Snippet: Mouse monoclonal anti-Gα13(Santa Cruz, Cat#sc293424),Mouse monoclonal anti-CD63 (Santa Cruz,Cat#sc- 5275),Rabbit polyclonal anti-Hsp70 (abcam, Cat#ab79852), Rabbit monoclonal anti-ALIX (abways, Cat#CY7215), Mouse monoclonal anti-GATA4 (Santa Cruz, Cat#sc- 25310), Mouse monoclonal antiSox9 (Santa Cruz, Cat#sc- 166505),Mouse monoclonal anti-DDDDK-Tag (ABclonal, Cat#AE005), Mouse monoclonal anti-HA-Tag (ABclonal, Cat#AE008), Rabbit monoclonal anti-BAX (abways, Cat#CY5059), Rabbit monoclonal anti-Bcl- 2 (abways, Cat# CY5032), Rabbit monoclonal anti-Cleaved Caspase- 3 (CST, Cat#9664), Rabbit monoclonal Anti-SQSTM1/p62 (PTM BIO, Cat#PTM- 6434), Rabbit monoclonal AntiLC3II(PTM BIO, Cat#PTM- 6384), Mouse monoclonal anti-STAT3 (Santa Cruz, Cat#sc- 293151),Rabbit monoclonal Anti-Rho A (abways, CatCY5640),Rabbit polyclonal anti-ARHGEF12 (proteintech, Cat#22,441– 1-AP), Rabbit monoclonal Anti-ATP1 A1 (PTM BIO, Cat#PTM- 6271), Rabbit monoclonal Anti-Calnexin (abways, Cat#CY5839), Mouse monoclonal anti-beta Actin (abways, Cat#AB0011).

Techniques: Expressing, Binding Assay, Transfection, Control, Plasmid Preparation, Immu-Puri, Mass Spectrometry, Silver Staining, Co-Immunoprecipitation Assay, Pull Down Assay, Western Blot, Immunostaining

( a ) Quantification of endothelial pore size in LARG, p115RhoGEF or Ect2 depleted ECs. ( b ) Quantification of endothelial pore size during early, mid and late diapedesis in control versus LARG+Ect2 depleted ECs. ( c ) Quantification of F-actin-positive ring structures and F-actin-positive apical protrusions in control versus LARG+Ect2 depleted ECs.( d ) Quantification of FITC–dextran and neutrophil extravasation after 20 min of neutrophil transmigration through control and Ect2/LARG ( d ) or ICAM-1-deficient ECs ( e ). ( f ) Model of endothelial pore formation. Adherent leukocytes destabilizing cell–cell junctions subsequently insert small pseudopodia between transient openings in the endothelium (leukocyte probing) during early diapedesis. The next step (mid diapedesis) involves local and transient RhoA activation that mediates endothelial pore confinement through the formation of a de novo basolateral F-actin ring and actomyosin contractility. Finally, persistent actomyosin contractility closes the endothelial pore behind transmigrating leukocytes. ICAM-1 is involved in the regulation of endothelial pore confinement through recruitment of the Rho GEFs LARG and Ect2. Basolateral F-actin ring formation and actomyosin contractility tightens the endothelial barrier during leukocyte diapedesis, making the leukocyte-induced endothelial pore impermeable for macromolecules. **** P <0.0001 (ANOVA) ( a – c ).** P <0.01 (ANOVA) ( b ) * P <0.05 (ANOVA) ( e , d ).* P <0.05 control versus siLARG/shEct2 ( d ) ** P <0.01 control versus siICAM-1 ( e ) (Student's t -test). Data are representative of three independent experiments ( a – e ) with >12 transmigration events per group ( a – c ) (error bars ( a – e ) s.e.m). ANOVA, analysis of variance.

Journal: Nature Communications

Article Title: F-actin-rich contractile endothelial pores prevent vascular leakage during leukocyte diapedesis through local RhoA signalling

doi: 10.1038/ncomms10493

Figure Lengend Snippet: ( a ) Quantification of endothelial pore size in LARG, p115RhoGEF or Ect2 depleted ECs. ( b ) Quantification of endothelial pore size during early, mid and late diapedesis in control versus LARG+Ect2 depleted ECs. ( c ) Quantification of F-actin-positive ring structures and F-actin-positive apical protrusions in control versus LARG+Ect2 depleted ECs.( d ) Quantification of FITC–dextran and neutrophil extravasation after 20 min of neutrophil transmigration through control and Ect2/LARG ( d ) or ICAM-1-deficient ECs ( e ). ( f ) Model of endothelial pore formation. Adherent leukocytes destabilizing cell–cell junctions subsequently insert small pseudopodia between transient openings in the endothelium (leukocyte probing) during early diapedesis. The next step (mid diapedesis) involves local and transient RhoA activation that mediates endothelial pore confinement through the formation of a de novo basolateral F-actin ring and actomyosin contractility. Finally, persistent actomyosin contractility closes the endothelial pore behind transmigrating leukocytes. ICAM-1 is involved in the regulation of endothelial pore confinement through recruitment of the Rho GEFs LARG and Ect2. Basolateral F-actin ring formation and actomyosin contractility tightens the endothelial barrier during leukocyte diapedesis, making the leukocyte-induced endothelial pore impermeable for macromolecules. **** P <0.0001 (ANOVA) ( a – c ).** P <0.01 (ANOVA) ( b ) * P <0.05 (ANOVA) ( e , d ).* P <0.05 control versus siLARG/shEct2 ( d ) ** P <0.01 control versus siICAM-1 ( e ) (Student's t -test). Data are representative of three independent experiments ( a – e ) with >12 transmigration events per group ( a – c ) (error bars ( a – e ) s.e.m). ANOVA, analysis of variance.

Article Snippet: Polyclonal goat antibody against LARG (Cat#AF4737) (1:1,000 for WB) was purchased from R&D systems.

Techniques: Pore Size, Control, Transmigration Assay, Activation Assay